Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
1.9%
0%
1.9%
6 Months
8.42%
0%
8.42%
1 Year
-10.06%
0%
-10.06%
2 Years
-25.12%
0%
-25.12%
3 Years
-51.51%
0%
-51.51%
4 Years
-74.48%
0%
-74.48%
5 Years
-82.61%
0%
-82.61%
Clal Biotechnology Industries Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-23.56%
EBIT Growth (5y)
0.88%
EBIT to Interest (avg)
-11.28
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
0.04%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
22.01%
ROE (avg)
19.99%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.44
EV to EBIT
-0.71
EV to EBITDA
-0.97
EV to Capital Employed
1.51
EV to Sales
1.35
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-211.66%
ROE (Latest)
-115.68%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'22 - YoY
Dec'22
Dec'21
Change(%)
Net Sales
0.10
17.30
-99.42%
Operating Profit (PBDIT) excl Other Income
-9.60
-29.60
67.57%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-6.40
-44.90
85.75%
Operating Profit Margin (Excl OI)
-162,816.70%
-2,020.40%
-16,079.63%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2022 is -99.42% vs -87.45% in Dec 2021
Consolidated Net Profit
YoY Growth in quarter ended Dec 2022 is 85.75% vs -142.88% in Dec 2021
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
0.40
0.60
-33.33%
Operating Profit (PBDIT) excl Other Income
-50.70
-46.10
-9.98%
Interest
3.60
3.50
2.86%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-75.10
-28.10
-167.26%
Operating Profit Margin (Excl OI)
-117,688.20%
-78,302.50%
-3,938.57%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -33.33% vs -86.96% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -167.26% vs 31.46% in Dec 2023






